Covid-19: WHO suspends UN supply of Covaxin over manufacturing deficiencies

Published On 2022-04-04 11:22 GMT   |   Update On 2022-04-04 11:23 GMT

The Bharat Biotech's COVID-19 vaccine, COVAXIN has been suspended by World Health Organization (WHO) from its Covax facility, announced the UN health body on Saturday attributing it to deficiencies in manufacturing practices."WHO confirms the suspension of supply of COVAXIN produced by Bharat (Biotech), through UN procurement agencies and recommending to countries that received the vaccine...

Login or Register to read the full article

The Bharat Biotech's COVID-19 vaccine, COVAXIN has been suspended by World Health Organization (WHO) from its Covax facility, announced the UN health body on Saturday attributing it to deficiencies in manufacturing practices.

"WHO confirms the suspension of supply of COVAXIN produced by Bharat (Biotech), through UN procurement agencies and recommending to countries that received the vaccine to take actions as appropriate," reads the WHO in a statement.

For more information, check out the full story on the link below:  

No Impact On Covaxin Safety, Clarifies Bharat Biotech After WHO Suspension

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News